Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties

American Heart Journal

Volumn 97, Issue 5, 1979, Pages 663-670

  Frishman, William ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ALPRENOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETALOL; BETAPTIN; DICHLORISOPRENALINE; IC 166082; ICI 150172; INDERAL AVLOCARDIN; ISOPRENALINE; M AND B 17,803 A; METOPROLOL; METOPROLOL TARTRATE; NADOLOL; OXPRENOLOL; PINDOLOL; PRACTOLOL; PROPRANOLOL; SOTALOL; TIMOLOL; TIMOLOL MALEATE; UNCLASSIFIED DRUG;

CARDIOVASCULAR SYSTEM; HEART; PHARMACODYNAMICS; PHARMACOKINETICS; SHORT SURVEY;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ARRHYTHMIA; BIOLOGICAL AVAILABILITY; HALF-LIFE; HUMAN; INTESTINAL ABSORPTION; PROTEIN BINDING; RECEPTORS, ADRENERGIC, BETA; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0018601266     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(79)90195-9     Document Type: Article

References (45)

1. A study of the adrenotropic receptors
2. Differentiation of receptor systems activated by sympathomimetic amines
3. Selective blockade of adrenoceptive beta receptors in the heart
4. Selectivity in beta-adrenergic response
5. Blocking of inhibitory adrenergic receptors by a dichloro-analog of isoproterenol
6. Pharmacology of a new adrenergic beta-receptor blocking compound (nethalide)
7. Status report on beta blockers
8. Untoward effect associated with practolol administration oculomucocutaneous syndrome
9. Fibrinous peritonitis: A complication of practolol therapy
10. Clinical pharmacology of beta receptor blocking drugs
11. The clinical pharmacology of beta-adrenoceptor blocking drug
12. Hypertension: which beta-blocker
13. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias
14. Pharmacologic properties of H 56/28 a beta adrenergic receptor antagonist
15. Pharmacological aspects of oxprenolol
16. β-adrenoceptor blocking properties and cardioselectivity of M and B 17, 803 A
17. Clinical aspects of the anti-arrhythmic action of beta-receptor blocking drugs. Part 2. Clinical Pharmacology
18. Plasma propranolol levels associated with suppressing of ectopic bouts
19. B-adrenergic receptor blocking drugs in cardiac arrhythmias
20. Comparison of the beta adrenergic blocking properties and negative inotropic effects of oxprenolol and propranolol in patients (Abstr)
21. Comparison of the hemodynamic effects of acute intravenous and oral therapy with propranolol and oxprenolol in hypertensive patients
22. Characterization of beta blockers as antihypertensive agents in the light of human pharmacology studies
23. Effects of oxprenolol on the airways of normal and bronchitic subjects
24. Pindolol (LB-46) therapy for supraventricular arrhythmia: A viable alternative to propranolol in patients with bronchospasm
25. Cardioselective beta adrenergic blockage
26. A comparison of the effect on airway resistance of a new beta blocking drug ICI 50, 172 and propranolol
27. Comparison of the effects of acebutolol (Sectral) and practolol on airways obstruction in asthmatics
28. Selective beta-1 receptor blockade with oral practolol in man
29. Clinical pharmacokinetics of β-adrenoreceptor blocking drugs
30. Pharmacokinetic properties of the β-adrenergic receptor blocking drugs
31. The metabolites of oxprenolol (Trasicor) in man
32. Pharmacokinetics of pindolol in man
33. Blood levels of practolol and oral and parenteral administration and their relationship to exercise heart rate
34. 3H) in the mouse and rat
35. The metabolism and distribution of the selective adrenergic beta blocking agent practolol
36. Binding of drugs to serum albumin, (second of two parts)
37. Binding of two adrenergic beta-receptor antagonists, alprenolol and H 93/26 to human serum proteins
38. Pharmacokinetics of practolol in renal failure
39. Pharmacodynamics of practolol in chronic renal failure
40. The effect on end-stage renal failure and hemodialysis on the elimination kinetics of sotulul
41. 14C-unlabelled pindolol in uraemia
42. Non-invasive assessment of clinical response to oral propranolol